This prospective, multi-center, open-label trial, CAN-BIND-1 was conducted between 2012 and 2017.
Your search for major depressive disorder returned 21 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
Previous studies have found that perinatal women have had detriments to sleep and depression during the pandemic; however, all studies to date in the perinatal setting have lacked a comparator group, so robust conclusions about the effect of the COVID-19 pandemic have not been elucidated.
Cognitive behavioral therapy for insomnia (CBT-I) has an overall benefit in the prevention of incident and recurrent major depression in older adults with insomnia disorder.
Differences in sleep patterns, which can be objectively measured with wrist-worn accelerometers, are the norm among patients with lifetime psychiatric conditions.
Solriamfetol, a dopamine-norepinephrine reuptake inhibitor, improves excessive daytime sleepiness in OSA regardless of primary OSA therapy adherence.
Longitudinal changes in the dopamine transporter availability may identify patients with idiopathic REM sleep behavior disorder who are at risk of conversion to neurodegenerative diseases.
Researchers looked to further connect the dots between cognitive behavioral therapy for insomnia and repetitive negative thinking.
Exploring the risk of alcohol use disorders in patients with insomnia.
Examining the potential shared genetic liability of sleep deficits and cannabis use behaviors using multiple genomic methods.
Serotonergic antidepressants are effective for sleep disturbances in perimenopausal and postmenopausal women even without major depressive disorder.